| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vinorelbine | GDSC1000 | pan-cancer | AAC | -0.095 | 0.007 |
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | 0.52 | 0.008 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.008 |
| mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.008 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.008 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.12 | 0.008 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | -0.08 | 0.009 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | -0.12 | 0.01 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | -0.084 | 0.01 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.01 |